Pharmacologic Reversal of Warfarin-Associated Coagulopathy in Geriatric Patients With Hip Fractures: A Retrospective Study of Thromboembolic Events, Postoperative Complications, and Time to Surgery

Geriatric Orthopaedic Surgery & Rehabilitation

Volumn 2, Issue 4, 2011, Pages 128-134

  Vitale, Mark A ^a   Vanbeek, Corinne ^a   Spivack, John H ^b   Cheng, Bin ^b   Geller, Jeffrey A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Department of Medicine   (United States)

Author keywords

anticoagulation; hip fracture; reversal; warfarin

Indexed keywords

EID: 84993783364     PISSN: 21514585     EISSN: 21514593     Source Type: Journal    
DOI: 10.1177/2151458511417434     Document Type: Article

References (46)

1. Salamat A Seaton J Watson HG. Impact of introducing guidelines on anticoagulant reversal. Transfus Med. 2005; 15(2):99–105.
2. Baglin TP Keeling DM Watson HG. Guidelines on oral anticoagulation (warfarin): third edition—2005 update. Br J Haematol. 2006; 132(3):277–285.
3. Francis CW Marder VJ Evarts CM Yaukoolbodi S. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. J Am Med Assoc. 1983; 249(3):374–378.
4. Carrel TP Klingenmann W Mohacsi PJ Berdat P Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis. 1999; 8(4):392–398.
5. Gallus AS Baker RI Chong BH Ockelford PA Street AM. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2000; 172(12):600–605.
6. Sandset PM Abildgaard U. Perioperative management of oral anticoagulant therapy. Thromb Res. 2002; 108(1):1–2.
7. Al-Rashid M Parker MJ. Anticoagulation management in hip fracture patients on warfarin. Injury. 2005; 36(11):1311–1315.
8. Parvizi J Viscusi ER Frank HG Sharkey PF Hozack WJ Rothman RR. Can epidural anesthesia and warfarin be coadministered?. Clin Orthop Rel Res. 2005; 456: 133–137.
9. Horlocker TT Wedel DJ Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA consensus conference on neuraxial anesthesia and anticoagulation). Reg Anesth Pain Med. 2003; 28(3):172–197.
10. Al-Ani AN Samuelsson B Tidermark J, et al. Early operation on patients with a hip fracture improved the ability to return to independent living. A prospective study of 850 patients. J Bone Joint Surg Am. 2008; 90(7):1436–1442.
11. Moran CG Wenn RT Sikand M Taylor AM. Early mortality after hip fracture: is delay before surgery important?. J Bone Joint Surg Am. 2005; 87(3):483–489.
12. Thakur NA Czerwein JK Butera JN Palumbo MA. Perioperative management of chronic anticoagulation in orthopaedic surgery. JAAOS. 2010; 18(12):729–738.
13. Ratnaweera M Janowski W Simmons D. Multiple thrombotic events following warfarin reversal. Intern Med J. 2007; 37(8):580–581.
14. García-Noblejas A Osorio S Durán AI, et al. Pulmonary embolism in a patient with severe congenital deficiency for factor V during treatment with fresh frozen plasma. Haemophilia. 2005; 11(3):276–279.
15. Yarranton H Cohen H Pavord SR Benjamin S Hagger D Machin SJ. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol. 2003; 121(5):778–785.
16. Flamholz R Jeon HR Baron JM Baron BW. Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?. J Clin Apher. 2000; 15(3):169–172.
17. Sullivan DW Purdy LJ Billingham M Glader BE. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A. Pediatrics. 1984; 74(2):279–281.
18. Marsh JL Slongo TF Agel J. Fracture and dislocation classification compendium–2007: orthopaedic trauma association classification, database and outcomes committee. J Orthop Trauma. 2007; 21(suppl 10):S1–S163.
19. Rodgers A Walker A Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomized trials. BMJ. 2000; 321: 1493–1497.
20. Richmond J Aharonoff GB Zuckerman JD Koval KJ. Mortality risk after hip fracture. J Orthop Trauma. 2003; 17(1):53–56.
21. Dowd P Ham SW Naganathan S Hershline R. The mechanism of action of vitamin K. Annu Rev Nutr. 1995; 15: 419–440.
22. Loebstein R Yonath H Peleg D, et al. Interindividual variability in sensitivity to warfarin–Nature or nurture?. Clin Pharmacol Ther. 2001; 70(2):159–164.
23. White RH McKittrick T Hutchinson R Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med. 1995; 122(1):40–42.
24. Dezee KJ Shimeall WT Douglas KM Shumway NM O'malley PG. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med. 2006; 166(4):391–397.
25. Whitling AM Bussey HI Lyons RM. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. Arch Intern Med. 1998; 158(19):2136–2140.
26. Raj G Kumar R McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999; 159(22):2721–2724.
27. Lubetsky A Yonath H Olchovsky D Loebstein R Halkin H Ezra D. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med. 2003; 163(20):2469–2473.
28. Fiore LD Scola MA Cantillon CE Brophy MT. Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis. 2001; 11(2):175–183.
29. Riegert-Johnson DL Volcheck GW. The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. Ann Allergy Asthma Immunol. 2002; 89(4):400–406.
30. Makris M Greaves M Phillips WS Kitchen S Rosendaal FR Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997; 77(3):477–480.
31. Fredriksson K Norrving B Strömblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke. 1992; 23(7):972–977.
32. Evans G Luddington R Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol. 2001; 115(4):998–1001.
33. Roback JD Caldwell S Carson J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010; 50(6):1227–1239. Epub 2010 Mar 19.
34. Kohler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res. 1999; 95(4 suppl 1):S13–S17.
35. Sjöblom L Hårdemark HG Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001; 32(11):2567–2574.
36. Hanley JP. Warfarin reversal. J Clin Pathol. 2004; 57(11):1132–1139.
37. Grundman C Plesker R Kusch M, et al. Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence. Thromb Haemost. 2005; 94(6):1338–1339.
38. Ansell J Hirsh J Dalen J, et al. Managing oral anticoagulant therapy. Chest. 2001; 119(1 suppl):22S–38S.
39. Baker RI Coughlin PB Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2004; 181(9):492–497.
40. Evans SJ Biss TT Wells RH Hanley JP. Emergency warfarin reversal with prothrombin complex concentrates: UK wide study. Br J Haematol. 2008; 141(2):268–269.
41. Dentali F Ageno W Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost. 2006; 4(9):1853–1863.
42. Tharmarajah P. Anticoagulation management in hip fracture patients on warfarin [Injury 2005;36:1311-1315]. Injury. 2006; 37(10):1029–1030; author reply 1030-1031.
43. Friedman SM Mendelson DA Bingham KW Kates SL. Impact of a comanaged Geriatric Fracture Center on short-term hip fracture outcomes. Arch Intern Med. 2009; 169(18):1712–1717.
44. Tharmarajah P Pusey J Keeling D Willett K. Efficacy of warfarin reversal in orthopedic trauma surgery patients. J Orthop Trauma. 2007; 21(1):26–30.
45. Shields RC McBane RD Kuiper JD Li H Heit JA. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy. Mayo Clin Proc. 2001; 76(3):260–266.
46. Cosgriff SW. The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy. Ann Intern Med. 1956; 45(1):14–22.